Literature DB >> 7818555

Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone.

T Inaoka1, G Bilbe, O Ishibashi, K Tezuka, M Kumegawa, T Kokubo.   

Abstract

We have previously cloned a rabbit cDNA clone (OC-2) from an osteoclast cDNA library by the differential screening. OC-2 was found to encode a novel cysteine proteinase, tentatively called cathepsin K, which is predominantly expressed in osteoclasts. By use of a rabbit OC-2 fragment as a probe, its human counterpart was cloned from a cDNA library of osteoarthritic hip bone. The cloned human cDNA (hOC-2) encoded a protein of 329 amino acid residues and its deduced amino acid sequence showed 94% homology to rabbit cathepsin K. Multiple alignment of amino acid sequences of human cathepsins B, H, L, S and K showed the highest homology of cathepsin K to cathepsin S 48%. Northern blot analysis showed that cathepsin K mRNA is expressed at high levels in some osteoarthritic hip bones and at a very high level in osteoclastoma compared to very low levels in other tissues. These results suggest that cathepsin K is closely involved in human osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7818555     DOI: 10.1006/bbrc.1995.1013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  55 in total

1.  Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

Authors:  W S Hou; D Brömme; Y Zhao; E Mehler; C Dushey; H Weinstein; C S Miranda; C Fraga; F Greig; J Carey; D L Rimoin; R J Desnick; B D Gelb
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.

Authors:  W F Rodrigues; M F M Madeira; T A da Silva; J T Clemente-Napimoga; C B Miguel; V J Dias-da-Silva; O Barbosa-Neto; A H Lopes; M H Napimoga
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.

Authors:  A F Schilling; C Mülhausen; W Lehmann; R Santer; T Schinke; J M Rueger; M Amling
Journal:  Osteoporos Int       Date:  2007-01-06       Impact factor: 4.507

Review 4.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

5.  Chondroitin sulfate promotes activation of cathepsin K.

Authors:  Peter A Lemaire; Lingyi Huang; Ya Zhuo; Jun Lu; Carolyn Bahnck; Shawn J Stachel; Steve S Carroll; Le T Duong
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

6.  Punicalagin attenuates osteoclast differentiation by impairing NFATc1 expression and blocking Akt- and JNK-dependent pathways.

Authors:  Mayumi Iwatake; Kuniaki Okamoto; Takashi Tanaka; Takayuki Tsukuba
Journal:  Mol Cell Biochem       Date:  2015-06-06       Impact factor: 3.396

Review 7.  Molecular aspects of osteoclast function.

Authors:  T J Hall; T J Chambers
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

8.  Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.

Authors:  D Brömme; J L Klaus; K Okamoto; D Rasnick; J T Palmer
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

9.  Osteocytes Acidify Their Microenvironment in Response to PTHrP In Vitro and in Lactating Mice In Vivo.

Authors:  Katharina Jähn; Shilpa Kelkar; Hong Zhao; Yixia Xie; LeAnn M Tiede-Lewis; Vladimir Dusevich; Sarah L Dallas; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2017-06-12       Impact factor: 6.741

Review 10.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.